Top FAP Inhibitor Companies Leading the Way in FAK Inhibitor Research FAK Inhibitors: Unlocking New Horizons in Targeted Cancer Therapy Focal Adhesion Kinase (FAK) inhibitors represent an exciting frontier in oncology, particularly in targeting tumor progression, metastasis, and resistance to therapies. FAK, a non-receptor tyrosine kinase, plays a vital role in cell adhesion, survival,...